Koch Industries, through its subsidiary Molex, is developing digital technology for home-based drug delivery. The system involves wearable sensors and injectable tubes interfaced with a smartphone app to monitor patient compliance and health metrics. The hosts describe this as a significant step toward invasive telemedicine.
